Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com
The company said it plans to use the net proceeds to purchase additional biomass, packaging materials and equipment, product development and for general corporate purposes Heritage Cannabis says it intends to issue up to 86 million units of the company at a price of $0.14 per unit Heritage Cannabis Holdings Corp () () (FRA:2UE) reported that it int
Pinto’s appointment follows the immediate resignation of Campbell Birge as chief executive officer and chief financial officer. Mojave Jane Brands Inc (CSE:JANE) (OTCMKTS:HHPHF) has appointed Mervyn Pinto as CEO, CFO, and as a director of the company.  In a statement Tuesday, the Toronto-based company said that Pinto is currently the president and
The company said it plans to use the net proceeds to purchase additional biomass, packaging materials and equipment, product development and for general corporate purposes It will provide further details on the offering price and number of units to be sold when it files the final short form prospectus Heritage Cannabis Holdings Corp () () (FRA:2UE)
Only company in North America to have developed a product line of hard pills for a variety of cannabinoid and terpenoid blends Holds a Cannabis Standard Processing & Sales for Medical Purposes License, a Cannabis Research License and an Industrial Hemp License from Health Canada. Tablets expected to be released this year () (OTCMKTS:CTABF) is d
Lexaria Bioscience (NASDAQ: LEXXW- CSE: LXX) CEO Chris Bunka joined Steve Darling from Proactive with news the company is planning for a very busy 2021 with a number of research and development initiatives. Bunka telling Proactive they are planning research on DehydraTECH-CBD For Hypertension and they are also looking at DehydraTECH with Antivirals
Canntab Therapeutics (CSE: PILL- OTCQB: CTABF) CFO Richard Goldstein joined Steve Darling from Proactive with news the company, which has filed over a dozen patents, has been granted their second in relation to its proprietary cannabidiol formulations around the hard pill format. Goldstein telling Proactive what this means for the company and he al
The new programs come on the heels of a recently-closed oversubscribed financing worth US$11 million Lexaria’s prospective business partners expect evidence that demonstrates initial effectiveness of DehydraTECH in improving drug delivery characteristics prior to entering negotiations Lexaria Bioscience Corp (NASDAQ:LEXX) () announced a pair of R&a
Canntab CEO Larry Latowsky told shareholders that the granting of the patent is another major milestone that confirms the group’s unique offering Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) announced Monday it has received a patent covering its proprietary cannabidiol formulations in Canada. The patent, which has a priority date of Jan
Australis said the greenhouse facility is expected to save up to 90% on water use and 90% on labour compared to a traditional farm The California greenhouse is expected to grow 48 million pounds of produce on a footprint 1/30th the size of a traditional farm  () () (FRA:AC4) reported that ALPS, a company in which Australis is in the process of acqu
Heritage said with these orders, it now has three brands available in Ontario, including the company’s newly-acquired Premium 5 brand Heritage Cannabis says it expects its tinctures to be in high demand based on sales from other provinces Heritage Cannabis Holdings Corp () () (FRA:2UE) reported that it has received the first order from the Ontario
CEO Iris Bincovich: 'The exercise of the warrants indicates that investors are confident in InnoCan Pharma' In other news, following the unexpected rise in sales on Shir Beauty's e-commerce platform, www.shirbeauty.com, InnoCan announced the full return of the website Corporation () (FSE:IP4) (OTCMKTS:INNPF) announced Thursday that since December 1
Novel drug delivery platform DehydraTECH masks unwanted tastes, improves onset speed, increases bioavailability of active ingredients Cannabis is the current focus, but company eyeing massive markets such as nicotine and painkillers Currently working on using DehydraTECH to deliver antiviral drugs and help in the global fight against coronavirus Le